Intelligent Bio Solutions ( (INBS) ) has shared an update.
On March 20, 2025, Intelligent Bio Solutions Inc. announced its expectation to receive a sixth U.S. patent, enhancing its intellectual property portfolio for its lateral flow technology used in the Intelligent Fingerprinting Drug Testing Solution. This development is crucial for the company’s strategy to expand its presence in the U.S. drug screening market, as it aims to meet the growing demand for non-invasive testing solutions. The anticipated patent will help protect the company’s proprietary technology as it prepares for U.S. market entry in 2025, positioning it to drive industry transformation and expand its global market presence.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. is a medical technology company specializing in innovative, rapid, non-invasive testing solutions. The company is known for its Intelligent Fingerprinting Drug Screening System, which uses fingerprint sweat analysis to detect recent drug use. This technology is designed to be hygienic and cost-effective, providing results in under ten minutes. It serves various industries, including construction, manufacturing, engineering, transport, logistics, drug treatment organizations, and coroners.
YTD Price Performance: 53.90%
Average Trading Volume: 204,802
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $14.37M
Learn more about INBS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com